NIPD Genetics is a leading innovative biotechnology company active in the field of developing, engineering and providing in vitro genetic testing solutions. NIPD Genetics was founded in 2010 to commercialize pioneering research work in the field of genetic testing. NIPD Genetics applies its proprietary genetic and bioinformatic analysis tools to develop novel tests and technologies for prognosis, prevention of genetic diseases, better clinical management and therapy. NIPD Genetics laboratories are accredited by CAP and certified by CLIA and ISO standards. We provide safe, accurate and reliable in vitro genetic testing services internationally. NIPD Genetics consists of a talented and multidisciplinary team of world-class experts and scientists with knowledge and experience in the fields of business, molecular biology, human genetics, genomics, transcriptomics, methylomics, statistics and bioinformatics. The NIPD Genetics R&D department consists of distinguished scientists from the best universities and research centres in Europe and America. They evaluate new ideas based on patient needs and develop innovative tests, which have clinical impact and improve quality of life. NIPD Genetics is led by an executive team with extensive experience in managing healthcare related organizations. The executive team is advised by a board of directors with several years of experience in raising funds and managing new ventures. The NIPD Genetics team has a very strong scientific publication track record in the field of in vitro genetic testing. Our scientists have published several original articles in prestigious peer-reviewed journals describing our innovative scientific work and cutting-edge technological advances. NIPD Genetics has also presented its pioneering work at several international scientific conferences demonstrating its leadership in the field of genetic testing.